SCHEMBL13940816

SCHEMBL13940816

Cc1ccc([C@@H](CN)CC(=O)O)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABBR2 O75899 5/20 0.70
GABBR1 Q9UBS5 5/20 0.70
LMNA P02545 2/20 0.69
CYP2C9 P11712 2/20 0.69
CYP3A4 P08684 1/20 0.69
ADORA3 P0DMS8 1/20 0.69
NFKB1 P19838 1/20 0.69
DRD3 P35462 1/20 0.69
BLM P54132 1/20 0.69
CYP1A2 P05177 1/20 0.69
CYP2D6 P10635 1/20 0.69
CYP2C19 P33261 1/20 0.69
MEN1 O00255 1/20 0.69
THRB P10828 1/20 0.69
TSHR P16473 1/20 0.69
KMT2A Q03164 1/20 0.69
GAA P10253 1/20 0.54
FFAR1 O14842 1/20 0.47
FNTA P49354 2/20 0.46
FNTB P49356 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18386267 1.00 GABBR2 (0.70) GABBR2GABBR1LMNACYP2C9CYP3A4
SCHEMBL2223571 0.88 FNTA (0.54) GABBR2GABBR1LMNACYP2C9CYP3A4
SCHEMBL11322774 0.83 FFAR1 (0.54) GABBR2GABBR1LMNACYP2C9CYP3A4
SCHEMBL2996427 0.83 FFAR1 (0.61) GABBR2GABBR1LMNACYP2C9CYP3A4
SCHEMBL28801346 0.83 GABBR2 (0.72) GABBR2GABBR1LMNACYP2C9CYP3A4
Phenibut SCHEMBL351501 0.82 GABBR2 (1.00) GABBR2GABBR1LMNACYP2C9CYP3A4
Phenibut SCHEMBL9545047 0.82 GABBR2 (1.00) GABBR2GABBR1LMNACYP2C9CYP3A4
Phenibut SCHEMBL340838 0.82 GABBR2 (1.00) GABBR2GABBR1LMNACYP2C9CYP3A4
Phenibut SCHEMBL28119792 0.81 GABBR2 (0.89) GABBR2GABBR1LMNACYP2C9CYP3A4
Baclofen SCHEMBL5556250 0.81 GABBR2 (1.00) GABBR2GABBR1LMNACYP2C9CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009017795-A1 INDAZOLE COMPOUNDS FOR TREATING INFLAMMATORY DISORDERS, DEMYELINATING DISORDERS AND CANCERS XANTHUS PHARMACEUTICALS, INC. (US) 2009-02-05 WO disclosed